Stay updated on Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Sign up to get notified when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.

Latest updates to the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, with no changes to the study details. There are no edits to core content such as eligibility criteria, primary outcomes, locations, or participant data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded New York as a location in the Locations section. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check55 days agoChange DetectedPublications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study. The page revision tag shows a change from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedDeleted the general maintenance notice about funding lapsed and NIH operations; the study page content remains unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedThe new screenshot shows only minor visual/layout updates with no changes to core study details such as the title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.